वेंकी रामाकृष्णन: लंबी उम्र जीने का विज्ञान और उसका हाइप (Hindi version)
Episode
47 min
Read time
2 min
Topics
Productivity, Health & Wellness, Investing
AI-Generated Summary
Key Takeaways
- ✓Defining Aging Scientifically: Aging is best understood as the accumulation of damage at the molecular, cellular, and tissue levels — not a single process but a cascade of dysfunctions. Understanding this distinction matters because it reveals why no single drug or supplement can reverse aging; interventions must target specific damage mechanisms rather than aging broadly.
- ✓Cellular Reprogramming Limitations: Billionaire-funded reprogramming research, including projects by Brian Johnson and others spending millions on stem cell therapies, faces a fundamental obstacle: cells within tissues are heterogeneous, meaning reprogramming clusters of mixed cell types produces unpredictable results. Current experiments remain highly limited and have not demonstrated reliable, scalable rejuvenation in humans.
- ✓Most Credible Near-Term Research: Calorie restriction pathways represent the most scientifically grounded short-term target in longevity research. These pathways are conserved across species, have measurable biological consequences, and have produced reproducible results in laboratory settings — making them a more reliable focus than blood transfusion therapies or cryopreservation, which lack equivalent evidence.
- ✓Eye Tissue Regeneration as Clinical Proof Point: Direct injection of reprogramming factors into damaged retinal tissue has entered approved clinical trials, representing one of the few longevity-adjacent interventions with regulatory validation. This localized approach — targeting a specific, contained tissue rather than whole-body reprogramming — illustrates the more realistic near-term path for regenerative medicine applications.
- ✓Exercise as the Strongest Longevity Tool: Exercise, specifically sustained aerobic activity such as cross-country skiing or elliptical training, demonstrably stimulates tissue rejuvenation and regeneration. Unlike ice baths, cold plunges, or saunas — which lack rigorous controlled trial evidence — regular aerobic exercise has consistent, replicated data supporting its role in slowing age-related decline across multiple biological systems.
What It Covers
Nobel Prize-winning structural biologist Venki Ramakrishnan speaks with Nicolai Tangen about the science of aging, separating credible longevity research from commercial hype, examining cellular reprogramming, calorie restriction pathways, blood exchange experiments, and why exercise remains the most evidence-backed intervention available today.
Key Questions Answered
- •Defining Aging Scientifically: Aging is best understood as the accumulation of damage at the molecular, cellular, and tissue levels — not a single process but a cascade of dysfunctions. Understanding this distinction matters because it reveals why no single drug or supplement can reverse aging; interventions must target specific damage mechanisms rather than aging broadly.
- •Cellular Reprogramming Limitations: Billionaire-funded reprogramming research, including projects by Brian Johnson and others spending millions on stem cell therapies, faces a fundamental obstacle: cells within tissues are heterogeneous, meaning reprogramming clusters of mixed cell types produces unpredictable results. Current experiments remain highly limited and have not demonstrated reliable, scalable rejuvenation in humans.
- •Most Credible Near-Term Research: Calorie restriction pathways represent the most scientifically grounded short-term target in longevity research. These pathways are conserved across species, have measurable biological consequences, and have produced reproducible results in laboratory settings — making them a more reliable focus than blood transfusion therapies or cryopreservation, which lack equivalent evidence.
- •Eye Tissue Regeneration as Clinical Proof Point: Direct injection of reprogramming factors into damaged retinal tissue has entered approved clinical trials, representing one of the few longevity-adjacent interventions with regulatory validation. This localized approach — targeting a specific, contained tissue rather than whole-body reprogramming — illustrates the more realistic near-term path for regenerative medicine applications.
- •Exercise as the Strongest Longevity Tool: Exercise, specifically sustained aerobic activity such as cross-country skiing or elliptical training, demonstrably stimulates tissue rejuvenation and regeneration. Unlike ice baths, cold plunges, or saunas — which lack rigorous controlled trial evidence — regular aerobic exercise has consistent, replicated data supporting its role in slowing age-related decline across multiple biological systems.
Notable Moment
Ramakrishnan challenges the entire anti-aging supplement and biohacking industry by pointing out that most popular interventions — cold plunges, saunas, specialized injections — have never been tested in properly controlled experiments, meaning consumers are essentially running unmonitored trials on themselves with no reliable outcome data.
Episode Transcript
Hello. In good company, may Nikolai Tangen, who, Norwegian sovereign wealth fund CEO. Thank you. Plan a plan Aging. Systems molecules, cells, or tissues damage or Mhmm. Or my aging define antiaging strategies damage damage or dysfunction strategies cells development or fertilized egg tissue or embryo cells cell tissue. In a pluripotent stem cells embryo develop stem cells specialized cells blood system cells nervous system cells cells cells cells cells class process normally real life. Mhmm. Mhmm. Or you're resetting perfect selection. Mhmm. Or John Gourdin or Nucleus Mhmm. Or is damage, main DNA damage. Mhmm. Damage Mhmm. Damage. Mhmm. Nobel Prize process damage repair mechanisms Average Mhmm. Or solve public health, vaccination, nutrition, or medicine Okay. Aging Example Mhmm. Excitement just research paper standard markers Any markers DNA damage reaction AI AI data patterns or is structural biology field is in a self sequence structures sequence gene sequencing example or aging complex or factors process DNA damage company isomorphic labs advisory board societies or health agencies society society society Mhmm. More everything forever. Or Rick Klausner chief scientist Mhmm. So or standard investment strategy. Calico, New Limit, Brian Armstrong, Brian Johnson. Brian Johnson billionaire million dollars stem cells stem cell research breakthrough reprogramming limited experiment. Or maybe reprogramming heterogeneous. Sales clusters reprogram or sales reprogram. Okay? Boston make interesting experiment. Your tissue regeneration restore. In factors direct inject eye tissue or as you damaged aging tissue restore retinal degeneration. So actually, clinical trials approved. Clinical trials sacrolinx stem cell injections. You know, log, for example, scientists connect blood supply exchange Okay. Cryopreservation. So basically freeze or freeze. Freeze. Freeze. Freeze. Freeze. Freeze. Freeze. Freeze. Freeze. Freeze. Freeze. Freeze. Freeze depend liquid nitrogen temperature. Okay? Comparison expand. Okay? Or Okay? Promising part aging research. Calorie restriction aging. Okay? Or species consequences calorie restriction pathways promising short term goal. Okay. Well, a possibility old blood or young blood differences or aging aging you know? Or, you know, sales damage. Promising area or third fourth part cellular reprogramming exciting long term goals You know, useful research calorie restriction pathway is a obvious answer. Suggest or baby lifetime life extend healthier or exercise or exercise rejuvenation or tissues regeneration to exercise actually stimulate Okay. Or, you know, You know? Night party animals. Exercise elliptical cross trainer. She said Norway appreciate cross country skiing. You know? Ice baths, cold plunges, or saunas or control experiment treatments Would you honestly doubt You know, drinking society society changes generations cut turn over. Society control society specially anti aging research or treatment highly sophisticated or expensive. Situation Thank you. Thank you. Physicist, Asal may biologist, For example, physicists physics control experiment experiment design you know? Or biology system control experiments or example biology or evolutionary term or naturally physics reductionist science physicist's complex systems traditionally highly reductionist science cultural differences transition successfully differences AI broad curriculum advantage broad curriculum advantage actually leverage powerful tool computation robotics tools, chemical tools, biological tools. AI powerful tool Royal Society president …
Get the full transcript (535 words) + summary by email — free
One-time email with the complete transcript and AI summary of this episode. No account needed.
One email, no spam. We’ll also show you what SignalCast does.
Browse all In Good Company with Nicolai Tangen transcripts →
You just read a 3-minute summary of a 44-minute episode.
Get In Good Company with Nicolai Tangen summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from In Good Company with Nicolai Tangen
Friday Wrap-Up: Leadership Longevity and Nicolai's biggest regret
Sep 4 · 14 min
The Indicator
Why Google fell behind in the AI race
Jul 9
More from In Good Company with Nicolai Tangen
John Deere CEO: Farming's Future, Autonomous Tractors and AI in the Field
Sep 2 · 38 min
The Joe Rogan Experience
#2549 - Jared Diamond
Sep 3
More from In Good Company with Nicolai Tangen
We summarize every new episode. Want them in your inbox?
Friday Wrap-Up: Leadership Longevity and Nicolai's biggest regret
John Deere CEO: Farming's Future, Autonomous Tractors and AI in the Field
Friday Wrap-Up: A Hedge Fund Legend and Reflections on the Global AI Race
Sir Paul Marshall: Why Markets Are Getting More Competitive, The Logic of Shorting, and Building TOPS
Ørsted CEO: Offshore Wind's Boom and Bust, America's Pushback and Rebuilding Trust
Similar Episodes
Related episodes from other podcasts
The Indicator
Jul 9
Why Google fell behind in the AI race
The Joe Rogan Experience
Sep 3
#2549 - Jared Diamond
Machine Learning Street Talk
Jun 22
He won a Nobel here for AlphaFold. Then he left. - John Jumper
Freakonomics Radio
May 27
The Brilliant Mr. Feynman (Update)
Freakonomics Radio
May 22
The Curious Mr. Feynman (Update)
Explore Related Topics
This podcast is featured in Best Business Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into In Good Company with Nicolai Tangen.
Every Monday, we deliver AI summaries of the latest episodes from In Good Company with Nicolai Tangen and 192+ other podcasts. Free for one show.
Start My Monday DigestNo credit card · Unsubscribe anytime